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ABSTRACT: Strategies aiming at controlling and modulating inflammatory cues may offer therapeutic solutions for improving tendon
regeneration. This study aims to investigate the modulatory effect of pulsed electromagnetic field (PEMF) on the inflammatory profile of
human tendon‐derived cells (hTDCs) after supplementation with interleukin‐1β (IL‐1β). IL‐1β was used to artificially induce in-
flammatory cues associated with injured tendon environments. The PEMF effect was investigated varying the frequency (5 or 17Hz),
intensity (1.5, 4, or 5mT), and duty‐cycle (10% or 50%) parameters to which IL‐1β‐treated hTDCs were exposed to. A PEMF actuation
with 4mT, 5Hz and a 50% duty cycle decreased the production of IL‐6 and tumor necrosis factor‐α (TNF‐α), as well as the expression of
TNFα, IL‐6, IL‐8, COX‐2, MMP‐1, MMP‐2, and MMP‐3, while IL‐4, IL‐10, and TIMP‐1 expression increased. These results suggest that
PEMF stimulation can modulate hTDCs response in an inflammatory environment holding therapeutic potential for tendon regenerative
strategies. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:160–172, 2020
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Tendons are musculoskeletal tissues with limited
healing and regenerative capacity. The inadequate ca-
pacity to heal toward mechano‐competent efficiency
and the involvement of inflammation mediators in
tendon injuries in general and tendinopathic conditions
in particular demands for new approaches to improve
healing and to encourage regeneration.1–3
Interleukin‐1β (IL‐1β) is a crucial pro‐inflammatory
mediator, secreted by immune cells and cells of some
connective tissues at the inflammation site4 with a
pivotal role in both homeostatic and pathological
mechanisms. Increased levels of IL‐1β have been de-
tected in tendons after prolonged mechanical loading
(overuse), a known risk factor for tendinopathy.4 The
exogenous supplementation of IL‐1β increases the ex-
pression of IL‐6, COX‐2, and MMPs5–7 in tendon cells8
and reduces the expression of tendon‐associated genes
such as scleraxis and tenomodulin and collagen 1 and 3
in injured tendon‐derived progenitor cells (TPCs).9
Blocking IL‐1β has been also reported to resolve in-
flammation in several inflammatory diseases.10 The
influence of IL‐1β in stimulating inflammatory cues
that are known to be present in tendon pathologies has
motivated its use as an in vitro model to study bio-
logical responses to inflammation‐conditioned niches.
The strategies for successful tendon treatments may
rely in the creation of innovative approaches to control
and guide inflammation toward proper healing envi-
sioning contributions for tendon regeneration.
Magnetic platforms have emerged as a technological
and versatile field of research to improve cell‐based
therapies and tissue engineering and regenerative
medicine approaches11–14 enabling the design of non‐
invasive and remote‐actuated systems to trigger and
modulate physiological processes, stimulating healing,
and regeneration. The clinical potential of magnetic
stimulation is enormous. Studies in the literature re-
ported a positive effect of magnetic actuation to improve
healing of non‐unions and delayed unions for treatment
of bone fractures and cervical spine fusion surgery.15,16
In recent years, pulsed electromagnetic field (PEMF)
actuation, which works by emitting a pulsating, varying
intensity, and frequency electromagnetic field, was re-
ported to modulate the cell processes. PEMF was shown
to decrease pro‐inflammatory cytokines such as IL‐1β
and tumor necrosis factor‐α (TNF‐α) and to increase
anti‐inflammatory cytokines as IL‐10 by tendon cells in
vitro,17–19 inhibited the synthesis of PGE2 and promoted
anabolic activity of the chondrocytes.17,19,20 In addition,
PEMF induced a downregulation of TNFα and factor
nuclear factor‐κB (NF‐κB) on macrophages, evidencing
the potential of PEMF‐actuated approaches for modu-
lating inflammatory responses. Despite the promising
outcomes and the remote actuation over inflicted tis-
sues, the cellular and molecular mechanisms involved
are still unveiled. Thus, we hypothesized that IL‐1β can
stimulate inflammatory cues in human tendon cells
(hTDCs) and be used as a model for inflammatory‐
compromised tendon niches. We also hypothesize that
the inflammatory response of IL‐1β‐conditioned hTDCs
can be modulated toward a non‐inflammatory/repair
response exposing hTDCs to PEMF actuation.
In this study, hTDCs were stimulated with different
concentrations of IL‐1β and exposed to six combinations
of PEMF parameters, namely magnetic field intensity
(1.5, 4, or 5mT), frequency (5 or 17Hz), and duty cycle
(10% or 50%), some of which referred to hold potential
in tendon inflammation‐related studies.17–19 As
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inflammation mediators have been associated to ten-
dinopathic conditions, recreating the inflammatory
cues of pathological environments combined with the
potential of PEMF to modulate the inflammatory pro-
file in hTDCs anticipates new opportunities ap-
proaching tendon regeneration.
MATERIALS AND METHODS
Cells: Isolation and Expansion
The hTDCs were isolated from surplus tissue samples of the
knee tendons and ligaments, namely patellar tendon, col-
lected from four adult patients undergoing orthopedic re-
constructive surgeries under protocols previously established
with Hospital da Prelada (Porto, Portugal) and with informed
consent of the patients. The healthy nature of the tissues was
confirmed at the surgery room by the orthopedic surgeon. The
hTDCs were isolated by enzymatic digestion of tendon sam-
ples with a solution of collagenase I from Clostridium histo-
lyticum.21–23 In brief, harvested samples were immersed in a
sterile solution of phosphate‐buffered saline (PBS; Sigma‐
Aldrich, Saint Louis, MO) with 2% antibiotic/antimicotic sol-
ution (A/A; Alfagene, Life Technologies Limited, Paisley, UK)
before being minced and digested in collagenase (C6885;
Sigma‐Aldrich, Saint Louis, MO) with 2M CaCl2 (VWR,
Darmstadt, Germany) (1:1,000) and 1% bovine serum albumin
(BSA) (Sigma‐Aldrich, Saint Louis, MO) for 1 h at 37°C under
agitation. The digested samples were filtered, centrifuged
three times at 1,200 rpm for 5min, and the supernatant dis-
carded. The hTDCs were expanded in α‐MEM (A‐MEM;
Alfagene, Life Technologies Limited, Paisley, UK) supple-
mented with 10% fetal bovine serum (FBS) (Alfagene, Life
Technologies Limited, Paisley, UK) and 1% A/A solution.
The multilineage differentiation potential and the cell
markers panel for stemness profile had been determined and
confirmed in previous studies using the described isolation
protocol.22
Inducing Inflammatory Cues in hTDCs With IL‐1β
The hTDCs, from passage 2‐4, were incubated for 16 h with
serum‐deprived αMEM medium and plated at 10,000 cells/cm2.
Afterward, the hTDCs were treated with exogenous IL‐1β (Al-
fagene, Life Technologies Limited, Paisley, UK) (0.01–1 ng/ml)
and cultured for 1, 2, 3, or 7 days. The cells were assessed for
cell viability, proliferation, and messenger RNA (mRNA) tran-
scriptional levels of metalloproteinases. The media was also
collected and screened for inflammatory cytokines.
Assessing the PEMF effect on hTDCs response to IL‐1β
stimulation
After pre‐selecting the best concentration of IL‐1β (1 ng/ml),
hTDCs were IL‐1β treated for 24 h before 1 h exposure to
different PEMF conditions using a Magnetotherapy device
(Magnum XL Pro; Globus Corporation, Italy) (Table 1). Af-
terward, the cells were cultured for 1, 2, 3, and 7 days and
assessed for cell viability, proliferation, mRNA transcriptional
levels of inflammatory‐associated markers, and protein dep-
osition. A non‐PEMF group (static control) was kept in iden-
tical conditions but without PEMF stimulation.
hTDCs Characterization
Metabolic Activity and Proliferation
The metabolic activity and proliferation of hTDCs were eval-
uated by MTS assay (CellTiter96® AQueous One Solution;
Promega Corporation, Madison) and Quant‐It PicoGreen
dsDNA assay kit (Thermo Fisher Scientific, Molecular Probes,
Eugene, OR), respectively. For the MTS assay, the samples
were washed with PBS and incubated with a mixture of
serum‐free medium without phenol red and MTS solution
(5:1 ratio) for 3 h at 37°C and 5% CO2, protected from light.
The supernatant was then transferred to a 96‐well plate and
the absorbance read at 490 nm (Synergy™HT; BIO‐TEK In-
struments, Winooski, Vermont). Samples were prepared in
triplicate and a blank reading (no cells) was performed.
For the dsDNA quantification assay, the samples were
washed with PBS and then transferred to a microtube con-
taining 1ml of sterile ultrapure water and kept at −80°C until
analysis. The samples were then thawed, sonicated, and an-
alyzed at an excitation/emission wavelength of 485/528 nm.
The samples and standards were made in triplicate.
Live and Dead Staining
The influence of PEMF on cell viability was also determined by
live/dead assay. The cells were incubated for 20min with calcein‐
AM (2 μg/ml), and propidium iodide (3 μg/ml), both from Life
Technologies Limited, Paisley, UK. Afterward, the cells were
washed with PBS and visualized under a fluorescence inverted
microscope (Axio Observer; ZEISS, Göttingen, Germany).
Cytokine Analysis
The release of pro‐inflammatory cytokines, IL‐6 and TNF‐α by
hTDCs was determined at day 1 and 3 after treatment with
IL‐1β and PEMF stimulation in culture medium and stored at
−80°C until analysis. The IL‐6 (900‐K16; Peprotech, Rocky Hill,
NJ) and TNFα (EK0525; Tebu‐Bio, Fremont, CA) concen-
trations were quantified using commercial enzyme human
immunoassay kits, following the manufacturer’s instructions.
RNA Isolation and Gene Expression Analysis
The total RNA was extracted using TRI reagent® RNA Iso-
lation Reagent (T9424; Sigma‐Aldrich, Saint Louis, MO) fol-
lowing the manufacturer’s instructions. RNA was quantified
using a Nanodrop® ND‐1000 spectrophotometer (Thermo
Fisher Scientific, Wilmington, DE) at 260 nm. The first‐strand
complementary DNAwas synthesized from 1 μg of RNA of each
sample (qScript™ cDNA Synthesis Kit; Quanta Biosciences,
Gaithersburg, MD) in a 20 μl reaction using a Mastercycler® ep
realplex gradient S machine (Eppendorf, Hamburg, Germany).
The quantification of the transcripts was carried out by
quantitative polymerase chain reaction (qPCR) using the
PerfeCTA SYBR Green FastMix kit (Quanta Biosciences,
Gaithersburg, MD) following the manufacturer’s protocol, in a
Real‐Time Mastercycler ep realplex thermocycler (Eppendorf,
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Table 1. Experimental Scheme of PEMF Parameters on
IL‐1β‐Treated hTDCs. The cells were exposed to one of the
following conditions for 1 h
Frequency (Hz) Intensity (mT) Duty Cycle (%)
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Hamburg, Germany). The primers were designed with
Primer3 software (Supplementary Table S1) and synthesized
by MWG Biotech. The 2 Ct−ΔΔ method was used to evaluate the
relative expression for each target gene.24
The transcript expression of target genes was analyzed and
normalized to the expression of endogenous housekeeping
gene GAPDH (glyceraldehyde‐3‐phosphate dehydrogenase)
and then to the samples collected at day 0 (n= 3).
Immunolocation Analysis
The cells were washed three times with warm PBS, before and
after fixation with 10% (v/v) neutral buffered formalin over-
night and kept in PBS at 4°C until usage. Subsequently, the
cells were incubated with 0.025% Triton‐X100 in PBS solution
(Sigma‐Aldrich, Saint Louis, MO) and the blocking step was
performed using RTU Normal Horse Serum (RTU Vectastain
Kit, PK‐7200; Vector, Burlingame, California). The hTDCs
cells were incubated overnight with connexin 43/GJA1, 1:100
(ab11370; Abcam, Cambridge, UK) and phospho‐p44/42
MAPK, 1:200 (Cell Signaling Technology, Danvers, MA), di-
luted in antibody diluent with background reducing compo-
nents (Dako, Santa Clara, CA) at 4°C, followed by 1 h
incubation at room temperature with the secondary antibody
(donkey anti‐rabbit Alexa Fluor 488, 1:200; Alfagene, Life
Technologies Limited, Paisley, UK). The samples were washed
three times with PBS and stained with 4′,6‐diamidino‐2‐
phenyindole, dilactate (DAPI, 5 μg/μl, D9564; Sigma‐Aldrich,
Saint Louis, MO) for 10min and with phalloidin‐tetra‐
methylrhodamine B isothiocyanate (Phalloidin), prepared
according to the manufacturer’s instructions (P1951, 1:200;
Sigma‐Aldrich, Saint Louis, MO).
All samples were observed under a microscope (Imager Z1m;
Zeiss, Göttingen, Germany) and images acquired using a digital
camera (AxioCam MRm5). A minimum of two wells per sample,
condition and endpoint were analyzed. Three independent ex-
periments were investigated for protein detection by immuno-
fluorescence.
Western Blot Analysis
The total cell lysates were prepared using RIPA buffer
(Sigma‐Aldrich, Saint Louis, MO) supplemented with pro-
tease inhibitor cocktail (Sigma‐Aldrich, Saint Louis, MO). The
samples were centrifuged for 15min at 14,000 rpm at 4°C and
the supernatants collected. The protein content was evaluated
using the BCA protein assay kit (Alfagene, Life Technologies
Limited, Paisley, UK) according to the manufacturer’s in-
structions.
The protein extracts of 15 μg were resolved in 10% sodium
dodecyl sulfate‐polyacrylamide gels, followed by semi‐dry
transfer to Amersham™ Protran® Western blotting mem-
branes (nitrocellulose; Sigma‐Aldrich, Saint Louis, MO),
using a Pierce Power Station (Thermo Fisher Scientific). The
membranes were blocked with 5% BSA in Tris‐buffered saline
with Tween 20 (Sigma‐Aldrich, Saint Louis, MO) (TBS‐T) and
incubated with rabbit anti‐phospho‐p44/42 MAPK (Erk1/2)
(1:1,000) (9102; Cell signaling Technology, Danvers, MA) and
anti‐α smooth muscle actin (1:2,000) (ab32575; Abcam, Cam-
bridge, UK) antibodies for 1 h at room temperature under
mild agitation. The membranes were washed three times with
TBS‐T and then incubated with a secondary antibody
(1:2,000) (Anti‐Rabbit IgG Alkaline Phosphatase antibody,
A9919, Sigma‐Aldrich, Saint Louis, MO) for 1 h at RT. A col-
orimetric AP substrate reagent kit (1706432; BioRad, Her-
cules CA) was used for color development.
Statistical Analysis
The results are expressed as mean± standard error of the
mean (SEM). The statistical analysis was performed using
GraphPad Prism6 software. Data were obtained from three
independent experiments (n= 3) analyzed in triplicate, and
evaluated by two‐way analysis of variance followed by mul-
tiple comparison tests. A difference was considered significant
with a confidence interval of 95% for different degrees of
confidence, p< 0.05, p< 0.01, p< 0.001, and p< 0.0001. A
multifactorial analysis was also performed to investigate the
impact of the PEMF, IL‐1β treatment and times, as well as
their potential interactions (PEMF × IL‐1β, PEMF × time,
IL‐1β × time) in the expression of individual genes, using
SPSS software (vs23) with a degree of confidence of p< 0.05.
RESULTS
Assessment of Human Tendon‐Derived Cells Response to
an IL‐1β‐Induced Environment
The metabolic activity and proliferation of hTDCs treated
with different concentrations of IL‐1β (0.01, 0.1, and
1ng/ml) increased between day 1 and 7, and tended to
increase with increasing concentrations of IL‐1β (Fig. 1A).
The MTS values showed an increase 3 and 7 days
after treatment with 1 ng/ml of IL‐1β in comparison
with all other concentrations (p< 0.05) and to non‐
treated hTDCs (control without IL‐1β, p< 0.05). Also,
dsDNA increased beyond 3 days in hTDCs treated with
1 ng/ml of IL‐1β (in comparison with non‐treated
hTDCs, p< 0.001).
In Figure 1B, secreted IL‐6 and TNF‐α increased in
IL‐1β treated hTDCs (1 ng/ml of IL‐1β, p< 0.0001) in an
IL‐1β concentration‐dependent manner. Moreover, a
significant increase in metabolic activity, gene ex-
pression, and release of cytokines was observed upon
hTDCs stimulation with 1 ng/ml of IL‐1β (p< 0.05),
(Fig. 1C and D). The expression of MMP‐1, MMP‐2, and
MMP‐3 increased for 1 ng/ml of IL‐1β p< 0.05 (Fig. 1C).
Altogether, the 1 ng/ml of IL‐1β stimulated more ef-
fectively inflammatory cues in hTDCs, being selected as
the most promising condition to be investigated in the
following PEMF‐actuated experiments.
Assessment of PEMF Parameters on IL‐1β‐Treated hTDCs
After the establishment of the optimal concentration of
IL‐1β (1 ng/ml) to stimulate inflammatory cues on hTDCs,
we investigated PEMF actuation to modulate the re-
sponse of IL‐1β treated hTDCs. Thus, the effect of mag-
netic field parameters namely strength, frequency, and
duty cycle were investigated on IL‐1β treated hTDCs.
Effect of PEMF Actuation in Metabolic Activity and Cell
Content of IL‐1β Treated hTDCs
Having in consideration previous studies,18–20 different
PEMF combinations of strength (1.5, 4, and 5mT),
frequency (5 and 17Hz), and duty cycle (10% and 50%)
were assessed (Table 1) on IL‐1β treated hTDCs. The
metabolic activity of IL‐1β treated hTDCs tended to
increase with time in culture for PEMF associated with
both frequencies studied, 5 and 17Hz (Figs. 2A and
3A). However, a decrease in the metabolic activity
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Figure 1. Effect of interleukin‐1β (IL‐1β) concentration (0.01, 0.1, and 1 ng/ml) on human tendon‐derived cells (hTDCs) for up to 7 days
in culture. (A) The metabolic activity was determined by the MTS assay and the cell content was determined by the PicoGreen assay. (B)
hTDCs relative expression of genes involved in extracellular matrix (ECM) remodeling: MMP‐1, matrix metalloproteinase 1; MMP‐2,
MMP‐3. (C) Profile of IL‐6 and tumor necrosis factor‐α (TNF‐α) cytokines secreted by hTDCs treated with different concentrations of IL‐
1β after 1 and 3 days in culture. (D) Cell metabolic activity, viability, and morphology of hTDCs cultured in the presence of 1 ng/ml of IL‐
1β. Ratio of metabolic activity and dsDNA content of hTDCs after 1, 3, and 7 days in culture. The morphology and viability of hTDCs
treated with 1 ng/ml of IL‐1β was also assessed 1, 3, and 7 days after pulsed electromagnetic field (PEMF) actuation by live and dead
staining. Viable and dead cells are represented in green and red, respectively (fluorescence microscopy ×20, scale bar 50 μm, merged
images). Results are presented as mean± standard error of the mean (SEM) (n= 3, experimental replicates from three biological rep-
licates) using two‐way analysis of variance (ANOVA) followed by multiple comparisons tests. Control condition refers to hTDCs without
IL‐1β treatment. Symbols and letters denote statistically significant differences with different degrees of confidence. Symbols *, $ denote
statistical differences for p< 0.05; **, λ for p< 0.01; ***, &, θ for p< 0.001; and ****, α for p< 0.0001. [Color figure can be viewed at
wileyonlinelibrary.com]
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(Figs. 2A and 3A) and viability (Figs. 2B and 3B) of
hTDCs was observed after exposure to a 5mT PEMF
with a 50% duty cycle, independently of the frequency
applied.
Considering the detrimental exposure of hTDCs to
5mT strength PEMF combined with a 50% duty cycle,
this condition was eliminated from the PEMF assess-
ment of IL‐1β treated hTDCs.
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Figure 2. Effect of 5Hz pulsed electro-
magnetic field (PEMF) in human tendon‐
derived cells (hTDCs) treated with
interleukin‐1β (IL‐1β) up to 7 days in the
culture. (A) Metabolic activity of hTDCs,
with a variation of intensity (1.5–5mT) and
duty cycle (10–50%, DC,%). (B) Live and
dead staining for viable (green) and dead
cells (red) in hTDCs cells 1, 3, and 7 days
(D1, D3, and D7), respectively, after PEMF
actuation (fluorescence microscopy ×20,
scale bar 50 μm, merged images). Insets are
representative images of hTDCs without
IL‐1β treatment (control). Results are pre-
sented as mean± standard error of the
mean (SEM) (n= 3), three experimental
replicates from three biological replicates)
and data analyzed using two‐way analysis
of variance (ANOVA) followed by multiple
comparisons tests (GraphPad Prism). Con-
trol condition refers to hTDCs without
IL‐1β treatment. Statistically, significant
differences are shown with different
degrees of confidence: *p< 0.05; **p< 0.01;
***p< 0.001; ****p< 0.0001 in comparison
with controls. [Color figure can be viewed at
wileyonlinelibrary.com]
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Figure 3. Effect of 17 Hz pulsed electromagnetic field (PEMF) in human tendon‐derived cells (hTDCs) treated with interleukin‐1β (IL‐
1β) up to 7 days in the culture. (A) Metabolic activity of hTDCs in function of intensity (1.5–5mT) and duty cycle (10–50%, DC,%) of
PEMF. (B) Live and dead staining for viable (green) and dead cells (red) in hTDCs cells 1, 3, and 7 days after actuation (fluorescence
microscopy × 20, scale bar 50 μm, merged images). Insets are representative images of hTDCs without IL‐1β treatment (control). Results
are presented as mean± standard error of the mean (SEM) (n= 3, three experimental replicates from three biological replicates) and data
analyzed using two‐way analysis of variance followed by multiple comparisons tests (GraphPad Prism). Statistically significant differ-
ences are shown with different degrees of confidence *p< 0.05; **p< 0.01; ***p< 0.001, ****p< 0.0001 in comparison with controls.
[Color figure can be viewed at wileyonlinelibrary.com]
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Influence of PEMF in the Cytokine Release Profile of IL‐1β
Treated hTDCs
The effect of PEMF parameters in the release of pro‐
inflammatory cytokines, IL‐6 and TNF‐α, by IL‐1β treated
hTDCs are presented in Figures 4 and 5, respectively.
In non‐PEMF conditions, IL‐6 and TNF‐α concen-
trations tended to increase in IL‐1β treated hTDCs.
When a PEMF is applied, IL‐6 concentration increased
with 5Hz PEMF combined with a 10% duty cycle for a
strength of 1.5, 4, or 5mT (Fig. 4A) but not with a 5Hz,
4mT PEMF 50% duty cycle, in which IL‐6 decreases in
comparison with controls (p< 0.001) (Fig. 4A). The ap-
plication of 17Hz PEMF resulted in a strongly increased
IL‐6 release in all conditions in comparison with IL‐1β
treated hTDCs without PEMF actuation (p< 0.0001)
(Fig. 4B).
The release of TNF‐α tended to increase after PEMF
exposure (Fig. 5A and B), with the exception for the
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Figure 4. Release of interleukin‐1β (IL‐6) after human tendon‐derived cells (hTDCs) treatment with IL‐1β and pulsed electromagnetic
field (PEMF) stimulation. (A) The effect of 5 Hz PEMF in IL‐6 levels secreted by hTDCs with a variation of intensity (1.5–5mT) and duty
cycle (10–50% DC,%); (B) The effect of 17Hz PEMF in IL‐6 levels secreted by hTDCs, with a variation of intensity (1.5–5mT) and duty
cycle (10–50 DC,%). IL‐6 was quantified in the culture medium 1 and 3 days after IL‐1β and PEMF stimulation. Results are presented as
mean ± standard error of the mean (SEM) (n= 4, experimental replicates from three biological replicates). Data were analyzed using a
two‐way analysis of variance (ANOVA) followed by multiple comparisons tests (GraphPad Prism). Statistically significant differences are
shown with different degrees of confidence: $ for p < 0.05; ** and λ for **p< 0.01; & for p< 0.001, and τ for p< 0.0001.
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5Hz and 4mT PEMF with a 50% duty cycle. As for the
IL‐6 release, the concentration of TNF‐α increased in
17Hz PEMF conditions (Fig. 5B).
In summary, hTDCs showed a reduced cytokine re-
lease after 1 h stimulation with a 5Hz and 4mT of in-
tensity PEMF combined with 50% of duty cycle,
suggesting a modulatory effect on pro‐inflammatory
cytokines in both physiological and inflammation‐
conditioned niches. Thus, this PEMF condition was
further investigated in the expression of inflammation‐
related genes of IL‐1β treated hTDCs.
PEMF Effect on the Genetic Profile of IL‐1β Treated hTDCs
The gene expression of pro‐inflammatory factors
(TNFα, IL‐6, IL‐8, IL‐1β, and COX‐2) was increased in
IL‐1β treated hTDCs in comparison with control
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Figure 5. Tumor necrosis factor‐α (TNF‐α) secreted after human tendon‐derived cells (hTDCs) treatment with interleukin 1β (IL‐1β)
and pulsed electromagnetic field (PEMF) stimulation. (A) The effect of 5 Hz PEMF in TNF‐α levels secreted by hTDCs with a variation of
intensity (1.5–5mT) and duty cycle (10–50% DC,%); (B) The effect of 17 Hz PEMF in IL‐6 levels secreted by hTDCs, with a variation of
intensity (1.5–5mT) and duty cycle (10–50 DC,%), TNF‐α was quantified in the culture medium 1 and 3 days after IL‐1β and PEMF
stimulation. Results are presented as mean± standard error of the mean (SEM) (n= 4, experimental replicates from three biological
replicates). Data were analyzed using a two‐way analysis of variance (ANOVA) followed by multiple comparisons tests (GraphPad Prism).
Statistically significant differences are shown with different degrees of confidence: *, $ for p< 0.05; λ for p< 0.01; ***, & for p< 0.001, and
τ for p< 0.0001.
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(p< 0.01) (Fig. 6). Furthermore, 5 Hz and 4mT PEMF
combined with 50% of duty cycle reduced the genetic
expression of IL‐6, TNFα, COX‐2, and IL‐8 in both non‐
treated and IL‐1β treated hTDCs (p< 0.05). In the
particular case of TNFα and COX‐2, the values found
for IL‐1β treated cells stimulated with PEMF are
lower than non‐PEMF stimulated hTDCs (p< 0.05).
Conversely, PEMF stimulated hTDCs showed an in-
crease in IL‐4 and IL‐10 in both IL‐1β treated and non‐
treated cells (p< 0.05) (Fig. 6). Overall, PEMF stimu-
lated cells showed increased anti‐inflammatory gene
expression over non‐stimulated cells, with IL‐1β
treated hTDCs and non‐treated hTDCs expressing
similar values.
The ECM remodeling and maturation during
healing depend on the balance of catabolic MMPs and
anabolic TIMPs. Thus, MMP‐1, ‐2, ‐3, and TIMP‐1
levels were also evaluated (Fig. 6). MMP‐1, ‐2, and ‐3
were upregulated in IL‐1β treated hTDCs in compar-
ison with non‐treated cells 1, 2, and 7 days (p< 0.05)
after IL‐1β supplementation (Fig. 6). After PEMF ac-
tuation, MMPs expression was considerably decreased
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Figure 6. Relative expression of genes related to inflammation and extracellular matrix (ECM) remodeling in human tendon‐derived
cells (hTDCs) treated with interleukin 1β (IL‐1β) and stimulated with pulsed electromagnetic field (PEMF) by reverse‐transcription
polymerase chain reaction (RT‐PCR) analysis. (A) Relative expression of pro‐inflammatory genes: IL‐6, TNFα, IL‐8, and COX‐2. (B)
Relative expression of anti‐inflammatory genes: IL‐4 and IL‐10. (C) Relative expression of ECM‐associated remodeling genes: MMP‐1,
MMP‐2, MMP‐3, and TIMP‐1. Results are presented as mean± standard error of the mean (SEM) (n= 3). Data were analyzed using a
two‐way analysis of variance (ANOVA) followed by multiple comparisons tests (GraphPad Prism). Control condition refers to hTDCs
without IL‐1β treatment. Statistically significant differences are shown with different degrees of confidence: *,Ψ, $, d, e for p< 0.05; **, λ,
δ, c for p< 0.01; ***, &, a, b for p< 0.001 and α, f for p< 0.0001.
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in both IL‐1β treated and non‐treated hTDCs (p< 0.05).
However, TIMP‐1 levels increased in non‐treated
hTDCs and decreased in IL‐1β treated hTDCs 7 days
after treatment (p< 0.01).
The multifactorial analysis performed showed that
TNFα expression is significantly affected by all the
parameters assessed: PEMF (p= 0.002), IL‐1β
(p= 0.026), and time (p= 0.042) while COX‐2 and
TIMP‐1 are influenced by the interaction of PEMF and
time (p= 0.002 and p= 0.004, respectively). IL‐4 is both
influenced by time (p= 0.037) and by the interaction of
IL‐1β with PEMF (p= 0.025).
ECM‐related genes, namely MMP‐1, is strongly influ-
enced by time (p= 0.011) and by the interaction effects of
time with PEMF (p= 0.021) and of time with IL‐1β
(p= 0.041). Interestingly, PEMF particularly influences
the MMP‐2 expression (p= 0.014) while MMP‐3 is more
influenced by the PEMFand time interactions (p= 0.028).
In summary, the cytokine gene profile was changed
upon exposure of hTDCs to a PEMF with 5Hz, 4mT and
an applied 50% duty cycle, evidencing the PEMF impact
in the expression of inflammation‐related genes. More-
over, the interactions between PEMF and time of culture
parameters also seem to play a role in the expression of
inflammatory cytokine genes and ECM‐related genes.
PEMF Effect on the Cell–Cell Communication of IL‐1β
Treated hTDCs
Cx43 expression associated to the cell–cell dissem-
ination of inflammatory cues is lower in IL‐1β treated
hTDCs after exposure to PEMF (Fig. 7A).
The influence of IL‐1β treatment and PEMF stim-
ulation in endogenous MAPK(Erk1/2) is not as clear as
for Cx43. MAPK(Erk1/2) immunolocation shows a de-
crease in the total protein after PEMF stimulation
(Fig. 7B). Western blot outcomes indicate a differential
detection in p42 and p44 bands of phospho‐MAPK
(Erk1/2). By day 1 it is increased in static control con-
ditions (day 1) and in IL‐1β treated hTDCs exposed to
PEMF (day 1). With the exception of static control
conditions, it tends to decrease by day 3 (Fig. 8).
DISCUSSION
The role of inflammation cues in healing and re-
generation depends on coordinated events with the
release of bioactive molecules and precise cell‐to‐cell
communication.
Previous works have demonstrated IL‐1β as an in-
flammation model in vitro,25,26 being able to stimulate
inflammatory mediators including COX‐2, MMPs, TNF‐α,
and IL‐6.5
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Figure 7. Representative images of Cx43 and MAPK expression in human tendon‐derived cells (hTDCs) treated with interleukin‐1β
(IL‐1β) and stimulated with pulsed electromagnetic field (PEMF). Fluorescence images of (A) Cx43 (green), nucleous (blue) and (B) MAPK
(green), nucleous (blue) immunolocation in hTDCs cells after 1, 3, and 7 days in the culture, D1, D3, and D7, respectively (fluorescence
microscopy ×20, scale bar 50 μm). Insets are representative images of hTDCs without IL‐1β treatment (control, bottom right) and to the
negative control (top right). Results are presented as mean± SEM (n= 3, three experimental replicates from three biological replicates).
[Color figure can be viewed at wileyonlinelibrary.com]
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In our study, the concentrations of IL‐1β investigated
increased cell proliferation beyond 3 days post‐
treatment (p< 0.05), which may relate to the IL‐1β in-
fluence in cell proliferation. Moreover, the significant
increment in MMPs (‐1, ‐2, and ‐3) around 100‐fold
suggests that hTDCs respond to IL‐1β treatment.
MMPs are responsible for the degradation of collagens
and proteoglycans and have been linked to the degen-
erative changes in chronic tendinopathy.27
The release of pro‐inflammatory cytokines IL‐6 and
TNF‐α tended to increase in IL‐1β concentration‐
dependent manner, which also suggests the role of
IL‐1β as an inflammatory inducer for hTDCs. Although
these outcomes were expected and complied with other
published works,28 they were necessary to establish the
optimal IL‐1β concentration (1 ng/ml) to induce in-
flammatory cues on hTDCs without causing detri-
mental or cytotoxic effect to the cells and to set IL‐1β
model for future tendon‐related studies.
In recent years, magnetic‐actuated technologies pro-
pose to offer remote control and non‐invasive tools to
trigger and control biological processes, therefore, the
promise of therapeutic value for the management and
treatment of tissue pathologies. The tendon cells ex-
posed to a 75Hz, 1.5mTmagnetic field for 8 h showed an
increment on IL‐10 expression without affecting the
production of pro‐inflammatory cytokines,19,29 while rat
Achilles tendons showed a reduction of inflammation
signals after a 17Hz PEMF exposure for 15min, five
sessions a week.20 However, studies on PEMF actuation
require further insights for the identification of the main
parameters or a combination of these holding a ther-
apeutic action to potentiate proper healing at the cel-
lular and tissue levels. Thus, we investigated sets of
PEMF parameters, namely frequency, intensity, and
duty cycle in modulating hTDCs cytokine profile.
An increase in cell metabolic activity, as well as an
elongated hTDCs shape, was observed after PEMF
exposure suggesting that the PEMF conditions
investigated did not exert a cytotoxic effect. An exception
was observed in hTDCs exposed to 5mT PEMFand 50%
duty cycle indicating that this condition is not favorable
for cellular processes. Also, these results suggest the
combination of 5mT and 50% duty cycle has more im-
pact in cell viability than any of the frequencies applied.
Overall, the PEMF parameters studied showed the po-
tential to modulate inflammatory cues of tendon cells
enabling external control in non‐invasive applications to
assist regeneration, whose parameters can be adjusted if
desirable, along the temporal healing timeline to pro-
mote the most suitable therapeutic action.
In the present study, IL‐1β induces an increment in
IL‐6 and TNF‐α secretion, antagonized by PEMF ac-
tuation with 5Hz, 4mT and 50% of duty cycle. This ef-
fect is also verified in non‐treated cells, suggesting that
PEMF may also influence cytokine profile in physio-
logical conditions. In terms of gene expression, the
PEMF application shows a modulatory effect in the ge-
netic profile of IL‐1β treated hTDCs. As mRNA levels of
inflammatory cytokines are remarkably upregulated in
injured tendons,9 the inhibition of IL‐1β via PEMF ac-
tuation could be beneficial for tendon‐healing strategies.
These outcomes are consistent with those of other
studies applying magnetic forces combined with 5, 17, or
75Hz frequencies.17,19,29 Accordingly, the strong IL‐1β‐
induction of MMP‐1 and MMP‐3 expression has been
demonstrated in rabbit Achilles tendon cells exposed to
cyclic strain and inflammatory cytokines.30 In our work,
PEMF stimulation not only decreases MMPs expression
but favors TIMP‐1 increment, suggesting a tentative
action of hTDCs toward an anabolic ECM turnover.
Connective tissues as tendons are excellent coupled
cell networks that can facilitate/stop the spread of in-
flammatory cues.31 The cell–cell communication estab-
lished via gap junction channels as connexin 43 is of
extreme importance to prevent or perpetuate in-
flammatory signals between cells. IL‐1β was reported to
stimulate an increase in Cx43 hemichannels32 via ac-
tivation of MAPK, iNOS, COX2, and PGE2. IL‐1β was
also described to increment the production of pro‐
inflammatory factors (IL‐1, IL‐17, IL‐8, TGF‐β, and
TNF‐α) in inflammation‐associated diseases via MAPK
pathway.33 Further, the upregulation of Cx43 by syno-
vial fibroblasts has been associated with the production
of pro‐inflammatory factors,34 proposing a functional
connection between IL‐1β, Cx43, and the propagation of
inflammation signals to neighboring cells.
In our study, the expression of Cx43 in IL‐1β treated
hTDCs was decreased after exposure to PEMF, which
can limit the IL‐1β‐mediated signaling cascade. Besides
the validation of IL‐1β to induce inflammatory cues on
the hTDCs, enabling studies on inflammation‐
conditioned niches, our outcomes disclose the potential
role of PEMFas an antagonist of hTDCs response to the
presence of pro‐inflammatory signals. The actuation of
5 Hz 4mT PEMF combined with 50% duty cycle led to a
decrease in the expression of pro‐inflammatory and
MMP genes and to a diminished expression of Cx43.
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Figure 8. Western blot assay for the detection of phosphory-
lated MAPK (pMAPK (Erk1/2). Whole cell protein lysates were
analyzed by probing for phospho‐MAPK(Erk1/2) and α‐smooth
muscle actin (control) in human tendon‐derived cells (hTDCs)
cells treated with interleukin 1β (IL‐1β) for 1, 3, and 7 days in the
culture (D1, D3, and D7) after pulsed electromagnetic field
(PEMF) stimulation (two experimental replicates from two bio-
logical replicates).
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MAPK signaling has been described to mediate mul-
tiple cell responses35,36 and could be involved in the re-
sponse of IL‐1β‐conditioned tendon cells stimulated with
PEMF. The tendon cells expressed pMAPK(Erk1/2) in all
conditions studied and immunochemistry studies pointed
that it was initially localized within the nucleus. Al-
though phosphorylation of MAPK (Erk1/2) is typically
associated with a translocation into the nucleus, cyto-
plasmic pMAPK(Erk1/2) also enables control over cell
fate,37 whose expression is increased in static con-
ditions.Moreover, in this study, p42 and p44 bands of
pMAPK(Erk1/2) were detected in all conditions by
western blotting. Interestingly though is the fact that
thicker bands were identified in static control and IL‐1β
treated hTDCs exposed to PEMF. The increment in
pMAPK(Erk1/2) of hTDCs exposed to PEMF treated with
IL‐1β did not correlate with the gene downregulation of
pro‐inflammatory markers TNF‐α and COX‐2 (in com-
parison with PEMFor IL‐1β alone). These results suggest
that complex signaling networks are likely involved in
triggering inflammatory cues in the tendon cells and that
these cues can be modulated by magnetic actuation.
CONCLUSIONS
The findings of this work show that PEMF parameters
of 5 Hz, 4mT, and 50% duty cycle can modulate the
response of tendon cells to induced inflammatory
stresses, influencing intracellular mechanisms at the
gene and protein levels, envisioning the applicability of
magnetic‐actuated therapies for tendon‐healing ap-
proaches.
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